UK AGM, EGM Calendar |
Wednesday, October 14 |
Imperial Innovations |
Diverse Income Trust |
Thursday, October 15 |
Filtronic |
IG Group Holdings |
Mattioli Woods |
Rank Group |
Renishaw |
HellermannTyton |
Friday, October 16 |
Mortice |
Monday, October 19 |
City of London Investment Group |
Tuesday, October 20 |
Scancell |
Mcbride |
Frontier Developments |
Copyright 2015 Alliance News Limited. All Rights Reserved. |
Scancell gets go-ahead for UK second phase trials of 'SCIB1'
(Sharecast News) - Cancer immunotherapy developer Scancell Holdings has received all of the UK regulatory, ethical and legal approvals required to initiate the phase 2 clinical trial to assess the safety and efficacy of 'SCIB1' in metastatic melanoma patients also receiving the checkpoint inhibitor pembrolizumab (Keytruda), it announced on Thursday.
Read more